Another pure play cell based meat investment is now available, accessible on the Tel Aviv stock exchange.

MeaTech (TLV: METC), based in Israel completed a reverse merger with Ophectra Real Estate, listed on the Tel Aviv stock exchange.

Background: MeaTech is developing a 3D stem cell printing technology for cell based meat production. The company’s founder and CEO Sharon Fima is an expert in complex 3D printing processes and is also the founder of Nano Dimension (Nasdaq: NNDM), a leading company in the printing sector.

Technological Niche: MeaTech isolates somatic stem cells from a bovine umbilical cord and grows these cells inside of a bioreactor. The cells are then differentiated into bioinks or edible inks to 3D print different cell types such as fat and muscle. Once the cells are 3D printed they are placed into incubators to mature and grow. This unique process allows for the development of structured meats such as steaks. https://cellbased.link/c0p

Bottom Line: MeaTech is currently the only cell based meat company integrating 3D bioprinting into the cell differentiation protocol.

Investments

London based cellular agriculture investment firm, Agronomics (ANIC) completed an equity fundraise of £5.5M through the issue of 78,571,429 Ordinary Shares at a price of $.09 per Ordinary Share. Funds were raised through Agronomics Joint Brokers, Zeus Capital Limited and Peterhouse Capital Limited. https://cellbased.link/op6

Publicity

🔥Wondering where to invest $1,000,000 right now? Kathlyn Tan, of Rumah Group says cell based meat. https://cellbased.link/ftz

Events

As cell based investment opportunities keep expanding, stay 👏 in 👏 the 👏 know by attending The Industrializing Cell- Based Meat Summit, March 24-26, 2020

Ryan Bethencourt, CEO Wild Earth is a keynote presenter discussing the topic: Creating Realistic Flavor in Cell-Based Meats & the advancements that have been made in the last 12 months to recreate realistic taste of meat.

Leo Groenewegen, CEO CellularRevolution will talk about continuous cell culturing techniques and creation of bioreactor capable of continuous cell production.

Paul Shapiro, Chief Executive Officer & Co founder, The Better Meat Co. providing an analysis on cross compatibility between current antibody purification methodologies & the needs of the cell-based meat industry.

Tickets: https://cellbased.link/tx8